| Literature DB >> 25005597 |
Moyez Jiwa1, Xingqiong Meng2, Carolyn O'Shea3, Parker Magin4, Ann Dadich5, Vinita Pillai1.
Abstract
OBJECTIVE: To determine how the timing and length of hospital discharge letters impact on the number of ongoing patient problems identified by general practitioners (GPs). TRIALEntities:
Keywords: PRIMARY CARE
Mesh:
Year: 2014 PMID: 25005597 PMCID: PMC4091507 DOI: 10.1136/bmjopen-2014-005475
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Participants (n=59)
| Sample | National population* | ||
|---|---|---|---|
| Mean | SD | Mean | |
| GP demographics | |||
| Age (years) | 44 | 11.1 | 50.5 |
| Years after graduation | 20 | 11.2 | |
| Years of GP experience | 15 | 11.4 | |
| GP sessions/week | 7 | 2.9 | |
| Number of GPs in the clinic | 8 | 4.2 | |
| Male | 31 | 52.5 | 60.9 |
| Graduated in Australia | 41 | 69.5 | 65.9 |
| Registrars | 11 | 18.6 | 3.8 |
| FRACGP | 37 | 62.7 | 56.8 |
| Principals | 13 | 22 | |
| Primary practice demographics | |||
| Accredited | 59 | 100.0 | 88.6 |
| Location | |||
| ACT | 1 | 1.7 | 1.5 |
| NSW | 7 | 11.9 | 33.1 |
| QLD | 5 | 8.5 | 19.5 |
| SA | 5 | 8.5 | 8.4 |
| TAS | 0 | 0.0 | 2.6 |
| VIC | 14 | 23.7 | 25.1 |
| WA | 27 | 45.8 | 9.1 |
| Remoteness | |||
| Major city | 42 | 71.2 | 71.1 |
| Inner regional | 9 | 15.2 | 18.9 |
| Outer regional | 4 | 6.8 | 8.1 |
| Remote | 4 | 6.8 | 0.9 |
| Patient consultations | |||
| Patient consultation h/week | |||
| <11 | 7 | 11.9 | 1.2 |
| 11–20 | 11 | 18.6 | 12.2 |
| 21–40 | 30 | 50.9 | 53.0 |
| 41–60 | 10 | 16.9 | 32.1 |
| >60 | 1 | 1.7 | 1.4 |
| Non-English consultations | |||
| No | 47 | 79.7 | |
| <25% | 11 | 18.6 | 21.7 |
| >50% | 1 | 1.7 | 2.8 |
*Sourced from national data when available.23–25
GP, general practitioner.
Health problems identified immediately after video (n=59)
| Health issue | Health problems identified | p Value* | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Group A | Group B | Group C | Group D | ||||||
| N | Per cent | N | Per cent | N | Per cent | N | Per cent | ||
| 1. Hypertension | 2 | 18.2 | 0 | 0.0 | 1 | 6.3 | 0 | 0.0 | 0.11 |
| 2. Diabetes | 2 | 18.2 | 5 | 27.8 | 1 | 6.3 | 1 | 7.1 | 0.31 |
| 3. Glaucoma | 1 | 9.1 | 2 | 11.1 | 0 | 0.0 | 0 | 0.0 | 0.41 |
| 4. Asthma | 2 | 18.2 | 4 | 22.2 | 8 | 50.0 | 2 | 14.3 | 0.14 |
| 5. Thyroid nodule | 9 | 81.8 | 2 | 11.1 | 16 | 100.0 | 0 | 0.0 | <0.001 |
| 6. Anticoagulation | 4 | 36.4 | 6 | 33.3 | 3 | 18.8 | 3 | 21.4 | 0.69 |
| 7. Social support | 3 | 27.3 | 5 | 27.8 | 5 | 31.3 | 1 | 7.1 | 0.40 |
| 8. Pulmonary embolism | 2 | 18.2 | 2 | 11.1 | 1 | 6.3 | 0 | 0.0 | 0.46 |
| 9. Colorectal cancer | 4 | 36.4 | 3 | 16.7 | 9 | 56.3 | 0 | 0.0 | 0.002 |
| 10. Anxiety | 6 | 54.6 | 9 | 50.0 | 13 | 81.2 | 2 | 14.3 | 0.003 |
| Number of identified problems | |||||||||
| Mean±SD | 3.2±2.2 | 2.1±2.5 | 3.6±1.5 | 0.6±1.5 | |||||
| Coefficient† | 0 (ref. group) | −1.07 | 0.38 | −2.54 | 0.001 | ||||
| 95% CI† | (−2.29 to 0.45) | (−1.18 to 1.94) | (−4.14 to 0.94) | ||||||
| 0.16 | 0.63 | 0.002 | |||||||
*p Values derived from Fisher's exact test.
†Results are derived from a linear regression and overall p value is derived from the Wald test.
GP views on discharge letter (n=59)
| Group A | Group B | Group C | Group D | p Value* | |||||
|---|---|---|---|---|---|---|---|---|---|
| N | Per cent | N | Per cent | N | Per cent | N | Per cent | ||
| Immediate discharge letter | |||||||||
| Timely | |||||||||
| Yes | 11 | 100.0 | 1 | 5.6 | 16 | 100.0 | 0 | 0.0 | <0.001 |
| No | 0 | 0.0 | 17 | 94.4 | 0 | 0.0 | 13 | 92.9 | |
| Unsure | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 7.14 | |
| Satisfaction | |||||||||
| Very satisfied | 0 | 0.0 | 8 | 50.0 | <0.001 | ||||
| Satisfied | 4 | 36.4 | 6 | 37.5 | |||||
| Neutral | 0 | 0.0 | 2 | 12.5 | |||||
| Dissatisfied | 7 | 63.6 | 0 | 0.0 | |||||
| Would prescribe | |||||||||
| Yes | 3 | 27.3 | 3 | 16.7 | 4 | 25.0 | 1 | 7.1 | 0.51 |
| No | 4 | 36.4 | 11 | 61.1 | 5 | 31.2 | 8 | 57.1 | |
| Unsure | 4 | 36.4 | 4 | 22.2 | 7 | 43.8 | 5 | 35.7 | |
| Would request investigation | |||||||||
| Yes | 8 | 72.7 | 10 | 55.6 | 16 | 100.0 | 3 | 21.4 | <0.001 |
| No | 2 | 18.2 | 3 | 16.7 | 0 | 0.0 | 8 | 57.1 | |
| Unsure | 1 | 9.1 | 5 | 27.8 | 0 | 0.0 | 3 | 21.4 | |
| Would make a referral | |||||||||
| Yes | 4 | 36.4 | 2 | 11.1 | 5 | 31.2 | 1 | 7.1 | 0.38 |
| No | 5 | 45.4 | 10 | 55.6 | 9 | 56.3 | 10 | 71.4 | |
| Unsure | 2 | 18.2 | 6 | 33.3 | 2 | 12.5 | 3 | 21.4 | |
| Would schedule another appointment | |||||||||
| Yes | 1 | 9.1 | 9 | 50.0 | 5 | 31.2 | 9 | 64.3 | 0.03 |
| No | 10 | 90.9 | 9 | 50.0 | 11 | 68.8 | 5 | 35.7 | |
| Delayed discharge letter | |||||||||
| Satisfaction | 0 | 0.0 | 4 | 28.6 | 0.03 | ||||
| Very satisfied | 7 | 38.9 | 8 | 57.1 | |||||
| Satisfied | 2 | 11.1 | 0 | 0.0 | |||||
| Neutral | 6 | 33.3 | 1 | 7.1 | |||||
| Dissatisfied | 3 | 16.7 | 1 | 7.1 | |||||
| Very dissatisfied | |||||||||
| Would prescribe | |||||||||
| Yes | 9 | 50.0 | 7 | 50.0 | 0.06 | ||||
| No | 6 | 33.3 | 1 | 7.1 | |||||
| Unsure | 0 | 0.0 | 4 | 28.6 | |||||
| No response | 3 | 16.7 | 2 | 14.3 | |||||
| Would request investigation | |||||||||
| Yes | 15 | 83.3 | 11 | 78.6 | 0.54 | ||||
| No response | 3 | 16.7 | 3 | 21.4 | |||||
| Would make a referral | |||||||||
| Yes | 6 | 33.3 | 3 | 21.4 | 0.22 | ||||
| No | 4 | 22.2 | 8 | 57.1 | |||||
| Unsure | 5 | 27.8 | 1 | 7.1 | |||||
| No response | 3 | 16.7 | 2 | 14.3 | |||||
| Would schedule another appointment | |||||||||
| Yes | 2 | 11.1 | 2 | 14.3 | 0.60 | ||||
| No | 16 | 88.9 | 12 | 85.7 | |||||
*p Values are derived from Fisher's exact test.
Health problems identified on receipt of delayed discharge letter (n=32)
| Health issue | Health problems identified | p Value* | |||
|---|---|---|---|---|---|
| Group B | Group D | ||||
| N | Per cent | N | Per cent | ||
| 1. Hypertension | 6 | 33.3 | 0 | 0.0 | 0.02 |
| 2. Diabetes | 4 | 22.2 | 5 | 35.7 | 0.45 |
| 3. Glaucoma | 3 | 16.7 | 0 | 0.0 | 0.24 |
| 4. Asthma | 4 | 22.2 | 4 | 28.6 | 0.70 |
| 5. Thyroid nodule | 17 | 94.4 | 10 | 71.4 | 0.14 |
| 6. Anticoagulation | 11 | 61.1 | 7 | 50.0 | 0.72 |
| 7. Social support | 4 | 22.2 | 2 | 14.3 | 0.67 |
| 8. Pulmonary embolism | 4 | 22.2 | 0 | 0.0 | 0.11 |
| 9. Colorectal cancer | 12 | 66.7 | 8 | 57.1 | 0.72 |
| 10. Anxiety | 8 | 44.4 | 2 | 14.3 | 0.12 |
| Number of identified problems | |||||
| Mean±SD | 4.1±2.1 | 2.7±1.7 | |||
| Coefficient (95% CI), p value† | 0.00 (ref. group) | −1.34 (−2.75 to 0.06), 0.06 | |||
*p Values derived from Fisher's exact test.
†Results are derived from a linear regression and overall p value is derived from the Wald test.
Regression models
| Variables | Linear regression models (number of health problems identified) | Variables | Binary logistic regression models (likelihood that the health problems would be identified) | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Model 1: phase I | Model 2: phase II | Model 3: phase I | Model 4: phase II | ||||||
| Coefficient | (95% CI) | Coefficient | (95% CI) | OR | (95% CI) | OR | (95% CI) | ||
| Group | Health problems | ||||||||
| A | 0.00 (ref) | – | Hypertension | 1.00 (ref) | – | 1.00 (ref) | – | ||
| B | −0.52 | (−1.84 to 0.79) | 0.00 (ref) | – | Diabetes | 3.62 | (1.10 to 11.95)* | 1.72 | (0.53 to 5.63) |
| C | 0.92 | (−0.28 to 2.12) | Glaucoma | 1.00 | (0.17 to 5.82) | 0.44 | (0.13 to 1.47) | ||
| D | −2.25 | (−3.64 to −0.87)** | −1.34 | (−2.69 to 0.00) * | Asthma | 8.18 | (2.14 to 31.37)** | 1.46 | (0.4 to 5.33) |
| Age | −0.15 | (−0.25 to −0.05)** | – | – | Thyroid nodule | 21.75 | (6.73 to 70.24)*** | 26.01 | (8.07 to 83.88)*** |
| Years of GP experience | 0.15 | (0.06 to 0.24)*** | – | – | Anti-coagulation | 8.18 | (2.18 to 30.74)** | 5.91 | (2.19 to 15.93)*** |
| Remoteness | Social support | 6.67 | (2.22 to 20.05)*** | 1.00 | (0.27 to 3.75) | ||||
| Major city | 0.00 (ref) | – | Pulmonary embolism | 1.77 | (0.36 to 8.81) | 0.61 | (0.19 to 2.02) | ||
| Inner regional | −1.35 | (−2.41 to −0.29) * | Colorectal cancer | 8.18 | (2.13 to 31.47)** | 7.74 | (2.68 to 22.4)*** | ||
| Outer regional | 2.68 | (0.60 to 4.76)* | Anxiety | 28.01 | (8.62 to 91.00)*** | 2.01 | (0.77 to 5.22) | ||
| Remote | 0.88 | (−1.03 to 2.78) | Group | ||||||
| Patient sessions per week | −0.36 | (−0.58 to −0.13)** | – | A | 1.00 (ref) | ||||
| Patient consultation h/week | B | 0.70 | (0.24 to 2.08) | 1.00 (ref) | |||||
| <11 | 0.00 (ref) | – | C | 1.58 | (0.69 to 3.66) | ||||
| 11–20 | 1.35 | (−0.17 to 2.87) | D | 0.14 | (0.03 to 0.67)* | 0.44 | (0.2 to 0.99)* | ||
| 21–40 | 2.30 | (0.75 to 3.84)** | Patient sessions per week | 0.79 | (0.63 to 0.99)* | – | – | ||
| ≥41 | 4.29 | (2.18 to 6.41)*** | Patient consultation h/week | ||||||
| <11 | 1.00 (ref) | ||||||||
| 11–20 | 1.97 | (0.49 to 7.82) | |||||||
| 21–40 | 5.63 | (0.92 to 34.55) | |||||||
| ≥41 | 14.61 | (1.68 to 127.3)* | |||||||
*p<0.05.
**p<0.01.
***p<0.001.
GP, general practitioner.